8-K - Aveo Pharmaceuticals, Inc. | Modeledge

Aveo Pharmaceuticals, Inc.

Filing type: 8-K
Filing date: Jan 18, 2023
Updated: Jan 19, 2023 · 9:35 AM

Filing

8-KEnd of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD

Exhibits

EX-3.1EX-3.1 EX-3.2EX-3.2 EX-99.1End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD